Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 3234
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT01740570 | Phase I/II Cabazitaxel for Recurrent Malignant Glioma | ||
| NCT04075305 | The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study | ||
| NCT00028418 | Clofarabine in Chronic Lymphocytic Leukemia | ||
| NCT02464696 | Non-invasive Ventilation in Reducing the Need for Intubation in Patients With Cancer and Respiratory Failure | ||
| NCT00543335 | Sorafenib and Thoracic Radiation for Patients With Non-Small Cell Lung Cancer | ||
| NCT03099850 | Prospective Evaluation of Chronic Pancreatitis for Epidemiologic and Translational Studies | ||
| NCT04589624 | An Investigational Scan (hpMRI) for Monitoring Treatment Response in Patients With Thyroid Cancer and Other Malignancies of the Head and Neck Undergoing Radiation Therapy and/or Systemic Therapy | ||
| NCT00386373 | Use and Tolerability of Imatinib Mesylate (Gleevec) in Leukemia Patients | ||
| NCT03136146 | Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia | ||
| NCT02684227 | Enzalutamide, Carboplatin, and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrioid Endometrial Cancer | ||
| NCT00493350 | Prospective Validation Trial of Circulating Tumor Cells (CTCs) in Women With Metastatic Breast Cancer | ||
| NCT00061620 | Phase I Study of Continuous Infusion Schedule of FMdC in Hematologic Malignancies | ||
| NCT00038168 | Intravenous Estramustine With Taxol in Hormone Refractory Prostate Adenocarcinoma | ||
| NCT01502150 | Data Collection of Normal Tissue Toxicity for Proton Therapy for Pediatrics | ||
| NCT01010217 | Mismatched Transplantation Using High-dose Post-transplant Cyclophosphamide | ||
| NCT00766220 | Yttrium Microspheres With Cetuximab Plus Irinotecan for Patients With Advanced Colorectal Cancer Mets to Liver | ||
| NCT02719847 | EBUS TBNA After PET/CT in Diagnosing Patients With Stage I-IIA Non-small Cell Lung Cancer Evaluated for Stereotactic Body Radiation Therapy | ||
| NCT00625638 | Interactive Voice Response System in Advanced Cancer Patients | ||
| NCT03106610 | Trial of Anti-PD-1 (Nivolumab) in Bladder Cancer Patients Recently Treated With Intravesical BCG Immunotherapy | ||
| NCT01436084 | SB1518 for Patients With Myelodysplastic Syndrome (MDS) | ||
| NCT00500578 | Intermittent Use of Aerosolized Ribavirin for Treatment of RSV | ||
| NCT00575718 | Smoking Cessation Intervention for Cancer Patients | ||
| NCT04837118 | Resistance Training Intervention to Improve Physical Function in Patients With Pancreatic Cancer Receiving Combination Chemotherapy or Have Undergone Surgery, PancStrength Study | ||
| NCT05034562 | Gallium-68 PSMA-11 PET in Participants With Prostate Cancer | ||
| NCT06085638 | Phase I/II Study of SY-1425 (Tamibarotene) in Combination With Azacitidine and Venetoclax for Patients With Chronic Myelomonocytic Leukemia | ||
| NCT04074746 | Modified Immune Cells (AFM13-NK) and A Monoclonal Antibody (AFM13) in Treating Patients With Recurrent or Refractory CD30 Positive Hodgkin or Non-Hodgkin Lymphomas | ||
| NCT03279250 | Apalutamide and Gonadotropin-Releasing Hormone Analog With or Without Abiraterone Acetate in Treating Participants With Prostate Cancer | ||
| NCT00299182 | Study of AMG 531 to Evaluate the Safety & Efficacy in Patients With Non-Hodgkin's Lymphoma | ||
| NCT00360438 | Pharmacokinetic Evaluation of Rasburicase in Patients With Leukemia and/or Lymphoma at High Risk of TLS | ||
| NCT00833625 | FDG-PET-CT and Biomarkers in Esophageal Cancer | ||
| NCT00826449 | Dasatinib and Erlotinib in Non-Small Cell Lung Cancer (NSCLC) | ||
| NCT05059678 | Parenting Support Intervention for Families Coping With Metastatic or Locally Recurrent Solid Tumor Diagnosis | ||
| NCT00037843 | Iodine I-131 Iodocholesterol, Its Use in Adrenal Screening | ||
| NCT00507754 | Latent Tuberculosis Infection in Cancer Patients | ||
| NCT02519322 | Neoadjuvant and Adjuvant Checkpoint Blockade | ||
| NCT02863172 | Molecular Basis for Variations in Hereditary Colorectal Cancer Syndromes | ||
| NCT06308575 | A Phase II Study of Rivoceranib for Patients With Recurrent or Metastatic Olfactory Neuroblastoma | ||
| NCT06722846 | Communicating Health Options to Inform Care and Empower Strategic Care Planning (CHOICES): A Multi-layer Randomized Case Vignette Study. | ||
| NCT02543294 | REcovery of Left Ventricular Dysfunction in CAncer Patients (RECAP Trial) | ||
| NCT00508573 | Registry for Women Who Are At Risk Or May Have Lynch Syndrome | ||
| NCT06287229 | Phase Ib/II Study Assessing the Clinical Activity and Safety of Brexucabtagene Autoleucel as a Consolidation in Patients With Relapsed/Refractory (R/R) and Newly Diagnosed B-cell Acute Lymphocytic Leukemia (ALL) Post Cytoreduction With Mini-HCVD-inotuzumab-blinatumomab/HCVAD-inotuzumab-blinatumomab | ||
| NCT03943173 | Olaparib in Treating Patients With Newly Diagnosed BRCA-Mutant Ovarian, Primary Peritoneal, or Fallopian Cancer Before Surgery | ||
| NCT06258551 | Dynamics of Colonization and Infection by Multidrug-Resistant Pathogens in Immunocompromised and Critically Ill Patients | ||
| NCT00290537 | Phase II Study of ZD6474 in Advanced NSCLC | ||
| NCT03450122 | Modified T Cells, Chemotherapy, and Aldesleukin With or Without LV305 and CMB305 in Treating Participants With Advanced or Recurrent Sarcoma | ||
| NCT00632437 | Intraoperative Optical Imaging of Brain Function | ||
| NCT00048737 | Safety and Efficacy of 90Y Zevalin in Nonmyeloablative Transplantation for Lymphoid Malignancies | ||
| NCT04119037 | Cordotomy in Reducing Pain in Patients With Advanced Cancer | ||
| NCT01067469 | Standard Dose Bevacizumab Versus Low Dose Bevacizumab Plus Lomustine (CCNU) for Recurrent Glioblastoma Multiforme (GBM) | ||
| NCT01875237 | Donor Lymphocyte Infusion (DLI) of T-cells Genetically Modified With iCasp9 Suicide Gene |
